Evis Havari

578 total citations
19 papers, 449 citations indexed

About

Evis Havari is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Evis Havari has authored 19 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Evis Havari's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (5 papers). Evis Havari is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (5 papers). Evis Havari collaborates with scholars based in United States, France and Slovakia. Evis Havari's co-authors include Myra A. Lipes, Bruce Roberts, Johanne Kaplan, Kai W. Wucherpfennig, William Siders, Roderick T. Bronson, Michael J. Turner, Bruno Kyewski, Shannon J. Turley and Huijuan Lv and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Evis Havari

17 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evis Havari United States 11 218 132 114 113 90 19 449
Manuel Alfonso-Pérez Spain 9 309 1.4× 113 0.9× 32 0.3× 131 1.2× 123 1.4× 11 547
Valentina Bardina Italy 9 157 0.7× 163 1.2× 24 0.2× 90 0.8× 67 0.7× 15 416
Miguel Guerrero Spain 13 193 0.9× 269 2.0× 24 0.2× 151 1.3× 62 0.7× 17 481
Christina Alter Germany 13 258 1.2× 38 0.3× 133 1.2× 133 1.2× 232 2.6× 24 632
Aina Teniente‐Serra Spain 15 290 1.3× 140 1.1× 14 0.1× 70 0.6× 91 1.0× 48 545
Matthew Weiland United States 11 102 0.5× 57 0.4× 69 0.6× 92 0.8× 360 4.0× 17 606
Rafet Başar United States 14 240 1.1× 33 0.3× 31 0.3× 248 2.2× 118 1.3× 25 465
Cristina López Spain 9 211 1.0× 220 1.7× 28 0.2× 113 1.0× 77 0.9× 11 415
Claudia Luther Germany 9 231 1.1× 54 0.4× 23 0.2× 53 0.5× 65 0.7× 10 405
Aidan Droogan United Kingdom 14 178 0.8× 291 2.2× 34 0.3× 81 0.7× 91 1.0× 21 535

Countries citing papers authored by Evis Havari

Since Specialization
Citations

This map shows the geographic impact of Evis Havari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evis Havari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evis Havari more than expected).

Fields of papers citing papers by Evis Havari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evis Havari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evis Havari. The network helps show where Evis Havari may publish in the future.

Co-authorship network of co-authors of Evis Havari

This figure shows the co-authorship network connecting the top 25 collaborators of Evis Havari. A scholar is included among the top collaborators of Evis Havari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evis Havari. Evis Havari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gruber, Ross C., Michael R. Dufault, Nellwyn Hagan, et al.. (2024). BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis. Nature Communications. 15(1). 10116–10116. 11 indexed citations
2.
Kühle, Jens, Nadia Daizadeh, Pascal Benkert, et al.. (2021). Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS. Multiple Sclerosis Journal. 28(4). 573–582. 26 indexed citations
3.
Gruber, Ross C., Michael R. Dufault, Nathalie Chrétien, et al.. (2021). Establishing a Role for the Bruton’s Tyrosine Kinase Inhibitor Tolebrutinib in Modulating Neuroinflammation and Disease Progression in MS (1974). Neurology. 96(15_supplement). 1 indexed citations
4.
Gruber, Ross C., Nathalie Chrétien, Michael R. Dufault, et al.. (2020). Central Effects of BTK Inhibition in Neuroinflammation (808). Neurology. 94(15_supplement). 10 indexed citations
5.
Siders, William, Ronnie R. Wei, Alison McVie‐Wylie, et al.. (2016). GZ402668, a Next-Generation Anti-CD52 Antibody, Displays Decreased Proinflammatory Cytokine Release In Vitro (P3.068). Neurology. 86(16_supplement). 3 indexed citations
6.
Turner, Michael, Evis Havari, Nathalie Chrétien, et al.. (2016). Characterization of a CD52 Knockout Mouse to Investigate the Function of CD52 (P5.323). Neurology. 86(16_supplement). 1 indexed citations
7.
Turner, Michael J., Petti T. Pang, Nathalie Chrétien, et al.. (2015). Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 285. 4–12. 27 indexed citations
8.
Havari, Evis, Michael J. Turner, James C. Dodge, et al.. (2014). Anti-murine CD52 antibody treatment does not adversely affect the migratory ability of immune cells. Journal of Neuroimmunology. 275(1-2). 62–63. 4 indexed citations
9.
Havari, Evis, Michael Turner, James C. Dodge, et al.. (2014). Anti-murine CD52 Antibody Treatment Does Not Adversely Affect the Migratory Ability of Immune Cells (P1.222). Neurology. 82(10_supplement). 2 indexed citations
10.
Turner, Michael J., Nathalie Chrétien, Evis Havari, et al.. (2013). Immune status following alemtuzumab treatment in human CD52 transgenic mice. Journal of Neuroimmunology. 261(1-2). 29–36. 45 indexed citations
11.
Havari, Evis, Michael J. Turner, Srinivas Shankara, et al.. (2013). Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro. Immunology. 141(1). 123–131. 59 indexed citations
12.
Nguyen, Tri‐Hung, William Weber, Evis Havari, et al.. (2012). Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia. International Journal of Oncology. 41(3). 829–838. 15 indexed citations
13.
Turner, Michael S., Nathalie Chrétien, Evis Havari, et al.. (2012). Anti-CD52 therapy in experimental autoimmune encephalomyelitis (116.5). The Journal of Immunology. 188(1_Supplement). 116.5–116.5. 1 indexed citations
14.
Nguyen, Tri‐Hung, Evis Havari, Mindy Zhang, et al.. (2011). Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes. Leukemia & lymphoma. 53(4). 699–709. 10 indexed citations
15.
Lv, Huijuan, Evis Havari, Sheena Pinto, et al.. (2011). Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans. Journal of Clinical Investigation. 121(4). 1561–1573. 160 indexed citations
16.
Nguyen, Tri‐Hung, Evis Havari, Rebecca G. Bagley, et al.. (2009). Abstract C166: Cancer cells expressing TMPRSS4 colocalized with carbonic anhydrase IX (CAIX)-positive cells in lung and pancreatic carcinomas. Molecular Cancer Therapeutics. 8(12_Supplement). C166–C166. 1 indexed citations
17.
Taylor, Jacqueline, Evis Havari, Marcia F. McInerney, et al.. (2004). A Spontaneous Model for Autoimmune Myocarditis Using the Human MHC Molecule HLA-DQ8. The Journal of Immunology. 172(4). 2651–2658. 39 indexed citations
18.
Havari, Evis, Ludger Klein, Jacqueline Taylor, et al.. (2004). Expression of the B7.1 Costimulatory Molecule on Pancreatic β Cells Abrogates the Requirement for CD4 T Cells in the Development of Type 1 Diabetes. The Journal of Immunology. 173(2). 787–796. 13 indexed citations
19.
Faradji, Raquel N., Evis Havari, Qian Chen, et al.. (2001). Glucose-induced Toxicity in Insulin-producing Pituitary Cells That Coexpress GLUT2 and Glucokinase. Journal of Biological Chemistry. 276(39). 36695–36702. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Alfonso-Pérez Breakdown of academic impact, for papers by Valentina Bardina Breakdown of academic impact, for papers by Miguel Guerrero Breakdown of academic impact, for papers by Christina Alter Breakdown of academic impact, for papers by Aina Teniente‐Serra Breakdown of academic impact, for papers by Matthew Weiland Breakdown of academic impact, for papers by Rafet Başar Breakdown of academic impact, for papers by Cristina López Breakdown of academic impact, for papers by Claudia Luther Breakdown of academic impact, for papers by Aidan Droogan
Rankless by CCL
2026